Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200)

Clinical Trial ID NCT02043665

PubWeight™ 3.62‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02043665

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology 2014 1.22
2 Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology 2015 0.83
3 Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1. Front Oncol 2014 0.82
4 Oncolytic virotherapy for urological cancers. Nat Rev Urol 2016 0.76
Next 100